Providence Regional Cancer Partnership Providence Reg. Cancer (2) — Everett, Washington

Providence Regional Cancer Partnership Providence Reg. Cancer (2) is a clinical research site located in Everett, Washington, United States 98201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Providence Regional Cancer Partnership Providence Reg. Cancer (2) has participated in 1 clinical trials.

Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Regional Cancer Partnership Providence Reg. Cancer (2)?

Providence Regional Cancer Partnership Providence Reg. Cancer (2) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Regional Cancer Partnership Providence Reg. Cancer (2) conducted?

Providence Regional Cancer Partnership Providence Reg. Cancer (2) has 1 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib.

Is Providence Regional Cancer Partnership Providence Reg. Cancer (2) accredited by Crixeo Health?

Providence Regional Cancer Partnership Providence Reg. Cancer (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Regional Cancer Partnership Providence Reg. Cancer (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.